468 studies found for:    Open Studies | "Glioma"
Show Display Options
Rank Status Study
21 Recruiting 5-ALA in Recurrent Glioma
Condition: Recurrent Glioma
Intervention: Drug: 5-ala
22 Recruiting Effects of Exercise on Cognitive Function in Glioma Patients
Conditions: Low Grade Glioma of Brain;   Anaplastic Glioma of Brain
Intervention: Behavioral: physical exercise
23 Recruiting 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Conditions: Adult Anaplastic (Malignant) Meningioma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Neoplasm;   Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Papillary Meningioma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Primary Melanocytic Lesion of Meninges;   Adult Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: Fluorine F 18 Fluorodopa;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Diffusion Weighted Imaging;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Temozolomide;   Other: Quality-of-Life Assessment
24 Not yet recruiting Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
Conditions: Diffuse Intrinsic Pontine Glioma;   Malignant Glioma;   Recurrent Childhood Brain Neoplasm
Interventions: Procedure: Diffusion Tensor Imaging;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Biological: Pembrolizumab;   Procedure: Perfusion Magnetic Resonance Imaging
25 Recruiting Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Recurrent Adult Brain Tumor
Interventions: Radiation: Hyperfractionated radiation therapy;   Radiation: Stereotactic radiosurgery;   Drug: Alisertib;   Procedure: Quality-of-life assessment
26 Recruiting Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
Condition: Malignant Glioma
Interventions: Radiation: Hypofractionated Stereotactic Irradiation (HFSRT);   Drug: Pembrolizumab;   Drug: Bevacizumab
27 Recruiting Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Conditions: Brain Tumor, Recurrent;   Glioblastoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Glioma
Interventions: Procedure: Cytoreductive surgery;   Drug: Perifosine;   Drug: Temsirolimus
28 Recruiting Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Conditions: High Grade Glioma: Glioblastoma (GBM);   High Grade Glioma: Gliosarcoma;   Anaplastic Astrocytoma (AA);   Anaplastic Oligodendroglioma (AO);   Mixed Anaplastic Oligoastrocytoma (AOA)
Interventions: Drug: Plerixafor;   Drug: Bevacizumab;   Procedure: Surgery
29 Recruiting Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Pineal Gland Astrocytoma;   Recurrent Adult Brain Tumor
Interventions: Biological: IL13Rα2-specific, hinge-optimized, 41BB-costimulatory CAR/truncated CD19-expressing T lymphocytes;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
30 Recruiting Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)
Conditions: Diffuse Intrinsic Pontine Glioma;   High-grade Glioma
Interventions: Drug: Crizotinib;   Drug: Dasatinib
31 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
Condition: Glioma
Intervention: Drug: 68Ga-BNOTA-PRGD2
32 Recruiting iMRI Guided Resection in Cerebral Glioma Surgery
Condition: Glioma
Interventions: Procedure: iMRI;   Procedure: conventional neuronavigation
33 Recruiting Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
Condition: Glioma
Intervention: Drug: nilotinib
34 Recruiting Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
Conditions: Childhood Mixed Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliosarcoma
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temozolomide;   Drug: Veliparib
35 Recruiting Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery
Condition: Glioma
Intervention: Drug: BLZ-100
36 Recruiting Dexamphetamine Sulfate in Patients With Glioma Suffering From Severe Asthenia
Condition: Glioma
Intervention: Drug: Dexamphetamine sulfate
37 Recruiting Carbon Ion Radiotherapy for Recurrent Gliomas
Condition: Glioma
Interventions: Radiation: Carbon Ion Radiotherapy;   Radiation: Fractionated Stereotactic Radiotherapy (FSRT)
38 Unknown  Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
Conditions: Epilepsy;   Glioma
Intervention:
39 Unknown  Gene Expression, Immunological Status and Metabolome in Glioma Patients
Condition: Glioma
Interventions: Procedure: Glioma resection;   Other: Blood sampling
40 Recruiting Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
Condition: Glioma
Interventions: Procedure: MRS Imaging;   Procedure: PET Scanning;   Procedure: Diffusion Tensor Imaging

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years